PhRMA, Infusion Centers Appeal Texas Court’s Dismissal Of IRA Case

By Gabrielle Wanneh / April 1, 2024 at 5:27 PM
The Pharmaceutical Research and Manufacturers of America (PhRMA), Global Colon Cancer Association (GCCA) and National Infusion Center Association (NICA) are seeking to revive their case against CMS’ Medicare drug price negotiation program following a Texas court’s dismissal of the lawsuit in February. The groups recently filed an appeal of the decision, arguing there’s good cause for the Fifth Court of Appeals to expedite their appeal due to ongoing and irreparable harm from the negotiations, the appeal’s inclusion of “purely legal...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.